News
SEATTLE, April 10, 2025--Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program ...
Other potential rivals in C3G include Apellis' C3 inhibitor Empaveli (pegcetacoplan), which recently generated positive phase 3 data, as well as Omeros Corp's antibody-based MASP-3 inhibitor ...
When interest rates are low, small-cap stocks begin to shine and outpace larger companies in value. These stocks are stocks with a market capitalization between $300 million and $3 billion.
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare ...
At close: 4:00:00 p.m. EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results